Search research articles
Contact Us
Filters
Showing results (41-50 of 356) with videos related to
Page
of 36
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1996
An economic model to assess the savings from a clinical application of haematopoietic growth factors
C A Uyl-de Groot, E Vellenga, F F Rutten
Advances in Experimental Medicine and Biology
|
May 20, 2017
DNA Methylation in Major Depressive Disorder
Ehsan Pishva, Bart P F Rutten, Daniel van den Hove
Transplantation
|
October 1, 1993
The cost-effectiveness of preservation with UW and EC solution for use in cadaveric kidney transplantation in the case of single kidney donors
F F Rutten, R J Ploeg, J McDonnell, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
February 13, 1993
[Cost-effectiveness analysis of human monoclonal antibody HA-1A in patients with sepsis syndrome]
B A Van Hout, F F Rutten, R H Lorijn
Health Services Research
|
January 1, 1975
Determinants of hospital utilization in the Netherlands
J van der Gaag, F F Rutten, B M van Praag
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Peripheral blood progenitor cell transplantation mobilised by r-metHuG-CSF (filgrastim); a less costly alternative to autologous bone marrow transplantation
C A Uyl-de Groot, D J Richel, F F Rutten
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Economic evaluation alongside cancer trials: methodological and practical aspects
G J Bonsel, F F Rutten, C A Uyl-de Groot
Health Policy (Amsterdam, Netherlands)
|
October 28, 1999
Assessment of biotechnology drugs: what are the issues?
J van Rijkom, H Leufkens, D Crommelin, et al.
Pharmacoeconomics
|
May 27, 1999
The burden of illness of hypopituitary adults with growth hormone deficiency
L Hakkaart-van Roijen, A Beckers, A Stevenaert, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
April 13, 1991
[Cost-effectiveness of lowering of blood cholesterol using simvastatin and cholestyramine]
L L Martens, F F Rutten, J L Kuijpens, et al.
Page
of 36
Search research articles
Search
Showing results (41-50 of 356) with videos related to
Sort By:
Page
of 36
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1996
An economic model to assess the savings from a clinical application of haematopoietic growth factors
C A Uyl-de Groot, E Vellenga, F F Rutten
Advances in Experimental Medicine and Biology
|
May 20, 2017
DNA Methylation in Major Depressive Disorder
Ehsan Pishva, Bart P F Rutten, Daniel van den Hove
Transplantation
|
October 1, 1993
The cost-effectiveness of preservation with UW and EC solution for use in cadaveric kidney transplantation in the case of single kidney donors
F F Rutten, R J Ploeg, J McDonnell, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
February 13, 1993
[Cost-effectiveness analysis of human monoclonal antibody HA-1A in patients with sepsis syndrome]
B A Van Hout, F F Rutten, R H Lorijn
Health Services Research
|
January 1, 1975
Determinants of hospital utilization in the Netherlands
J van der Gaag, F F Rutten, B M van Praag
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Peripheral blood progenitor cell transplantation mobilised by r-metHuG-CSF (filgrastim); a less costly alternative to autologous bone marrow transplantation
C A Uyl-de Groot, D J Richel, F F Rutten
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Economic evaluation alongside cancer trials: methodological and practical aspects
G J Bonsel, F F Rutten, C A Uyl-de Groot
Health Policy (Amsterdam, Netherlands)
|
October 28, 1999
Assessment of biotechnology drugs: what are the issues?
J van Rijkom, H Leufkens, D Crommelin, et al.
Pharmacoeconomics
|
May 27, 1999
The burden of illness of hypopituitary adults with growth hormone deficiency
L Hakkaart-van Roijen, A Beckers, A Stevenaert, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
April 13, 1991
[Cost-effectiveness of lowering of blood cholesterol using simvastatin and cholestyramine]
L L Martens, F F Rutten, J L Kuijpens, et al.
Page
of 36